ERBB2 and breast cancer: Consistent with the online TCGA and METABRIC database, POU4F1 expression, determined by immunohistochemistry staining, was significantly higher in breast cancer tissues of TNBC patients, compared with ones of luminal A, luminal B and HER2‐positive breast cancer patients and normal breast tissues (Figure 1G).